The hardest markets can offer the strongest competitive advantages to companies willing to understand them.

Conventional wisdom on market selection rewards speed over staying power. Founders are told to look for an obvious buyer and a short sales cycle, because both lead to early revenue, and early revenue is what most boards and investors want to see first.

However, after twenty years inside healthcare, I’ve watched well-built companies stall while patient ones grow, and the pattern has become difficult to miss. The markets everyone avoids end up protecting the companies willing to learn them, and the difficulty everyone complains about turns out to be the most durable competitive advantage.

This is not a romantic argument for suffering. Plenty of companies walk into hard markets and die there, usually with strong products and hard-working teams. The difference between the companies protected by complexity and the companies killed by it has little to do with product quality and nearly everything to do with whether anyone studied the market’s structure before deploying capital against a well-informed strategy. The moat prizes residents and drowns tourists, and both walk in through the same gate.

An easy market gives you validation fast, with revenue settling the argument before the next board meeting. What rarely gets priced is the other side of the ledger. Every condition making a market easy for you makes it equally easy for whoever comes next. Competitors show up fast, features converge faster, and before long, price is the only argument left. The speed of validation and the speed of commoditization are the same speed.

Source link